Lotte & John Hecht Memorial Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Vancouver Canada (1962)

Organization Overview

First Clinical Trial
2007
NCT00668707
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Lotte & John Hecht Memorial Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Attention Deficit Disorder with Hyperactivity (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Colorectal Neoplasms (Phase 2)

Coronavirus Infections (Phase 3)

Hyperkinesis (Phase 2)

Lung Neoplasms (Phase 3)

Pancreatic Neoplasms (Phase 1)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 18